235 related articles for article (PubMed ID: 10510445)
1. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages.
Kang YJ; Koo EB; Lee YS; Yun-Choi HS; Chang KC
Br J Pharmacol; 1999 Sep; 128(2):357-64. PubMed ID: 10510445
[TBL] [Abstract][Full Text] [Related]
2. A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock.
Kang YJ; Seo SJ; Yun-Choi HS; Lee DH; Kim YM; Chang KC
J Pharmacol Exp Ther; 2002 May; 301(2):561-7. PubMed ID: 11961057
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root.
Kang YJ; Lee YS; Lee GW; Lee DH; Ryu JC; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 1999 Oct; 291(1):314-20. PubMed ID: 10490919
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10.
Ruetten H; Thiemermann C
Shock; 1997 Dec; 8(6):409-14. PubMed ID: 9421853
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid.
Kang YJ; Lee BK; Lee YS; Seo HG; Park MK; Kim HJ; Pyo HS; Chong WS; Jung HJ; Yun-Choi HS; Lee DH; Chang KC
Biochem Pharmacol; 2003 Feb; 65(3):457-64. PubMed ID: 12527339
[TBL] [Abstract][Full Text] [Related]
6. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
Zhou J; Struthers AD; Lyles GA
Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
[TBL] [Abstract][Full Text] [Related]
8. Dantrolene inhibits nitric oxide synthase in rat alveolar macrophages treated with lipopolysaccharide and interferon-gamma.
Li CY; Chou TC; Wu CC; Wong CS; Ho ST; Yen MH; Ding YA
Can J Anaesth; 1998 Mar; 45(3):246-52. PubMed ID: 9579263
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells.
Paul A; Doherty K; Plevin R
Br J Pharmacol; 1997 Mar; 120(5):940-6. PubMed ID: 9138702
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
Moreau R; Barrière E; Tazi KA; Lardeux B; Dargère D; Urbanowicz W; Poirel O; Chauvelot-Moachon L; Guimont MC; Bernuau D; Lebrec D
Hepatology; 2002 Nov; 36(5):1070-8. PubMed ID: 12395316
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
13. Enantiomers of higenamine inhibit LPS-induced iNOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia.
Park JE; Kang YJ; Park MK; Lee YS; Kim HJ; Seo HG; Lee JH; Hye Sook YC; Shin JS; Lee HW; Ahn SK; Chang KC
Int Immunopharmacol; 2006 Feb; 6(2):226-33. PubMed ID: 16399627
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
17. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates.
Ryu YS; Lee JH; Seok JH; Hong JH; Lee YS; Lim JH; Kim YM; Hur GM
Biochem Biophys Res Commun; 2000 Jun; 272(3):758-64. PubMed ID: 10860828
[TBL] [Abstract][Full Text] [Related]
18. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
Wu CC; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1273-81. PubMed ID: 7542532
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase.
Yamada T; Fujino T; Yuhki K; Hara A; Karibe H; Takahata O; Okada Y; Xiao CY; Takayama K; Kuriyama S; Taniguchi T; Shiokoshi T; Ohsaki Y; Kikuchi K; Narumiya S; Ushikubi F
Circulation; 2003 Nov; 108(19):2381-6. PubMed ID: 14557367
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by N-acetyl-5-hydroxytryptamine of nitric oxide synthase expression in cultured cells and in the anaesthetized rat.
Klemm P; Hecker M; Stockhausen H; Wu CC; Thiemermann C
Br J Pharmacol; 1995 Aug; 115(7):1175-81. PubMed ID: 7582541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
